Liver Cancer Prevention: Essential Screening Tests to Consider

To effectively prevent liver cancer, regular screening tests are crucial, particularly for individuals at higher risk. The primary diagnostic tools include blood tests and imaging examinations. One of the most commonly used blood markers is AFP (Alpha-Fetoprotein), which plays a significant role in detecting potential liver abnormalities.

Elevated AFP levels can be an early warning sign. If AFP remains above 400 ng/mL for more than a month, or exceeds 800 ng/mL for two consecutive weeks, it may indicate a high risk of liver cancer. However, these results should be interpreted alongside imaging findings or existing liver disease history for more accurate diagnosis.

Imaging tests such as ultrasound and CT scans are highly recommended. These tools can reveal space-occupying lesions in the liver or signs of metastasis. When combined with abnormal blood results, imaging provides a clearer picture of liver health and potential malignancies.

In addition to AFP, other blood tests can also be valuable. Liver function tests including alkaline phosphatase and hepatitis B surface antigen offer insight into overall liver performance and possible viral infections. Assessing the degree of liver cirrhosis is also important, as advanced scarring significantly increases cancer risk.

Regular monitoring is key for at-risk individuals. Those with chronic hepatitis B or C, a family history of liver cancer, or long-term liver disease should undergo routine screenings. Combining blood analysis with imaging studies provides the most effective strategy for early detection and prevention.

Consultation with a healthcare provider is essential. Based on personal health history and risk factors, a physician can recommend the most appropriate screening schedule. Early detection dramatically improves treatment outcomes and survival rates in liver cancer cases.